Thin-layer chromatography was carried out on silica plates (Merck 5554), visualised under UV irradiation (254 nm), with iodine staining or using potassium permanganate dip. Where required, compounds were purified using either manual chromatography using silica gel (SiliCycle R12030B) or a Varian 971-FP flash chromatography system using pre-packaged silica gel columns (Luknova). 
Instrumentation and methods

NMR
Mass Spectrometry
Electrospray-Ionisation MS (ESI-MS) data were acquired on a Q-Tof Ultima mass spectrometer (Waters) operated in the positive ionization mode and fitted with a standard Z-spray ion source equipped with the Lock-Spray TM interface. The samples were diluted in CH 3 The solutions and refinements were performed by SHELX. 3 The crystal structures were refined using full-matrix least-squares based on F 2 with all non hydrogen atoms anisotropically defined.
Hydrogen atoms were placed in calculated positions by means of the "riding" model. Disorder problems were encountered during the refinement of complex 2a and 5a and treated by the split model. Additional electron density (due to very disordered water molecules) was found in the difference Fourier map of compound 5a and treated by the SQUEEZE algorithm of PLATON.
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Miscellaneous UV-Vis absorbance spectra were recorded on a JASCO V-550 UV/VIS spectrophotometer (using Spectra Manager software (version 1.53.01)).
Melting points were measured using a Stuart Scientific SMP3 apparatus and are uncorrected.
Elemental analysis was carried out at the EPFL by the microanalytical laboratory using a Thermo Scientific Flash 2000 Organic Elemental Analyzer.
A SpectroMax M5e multi-mode microplate reader was used to record the absorbance of solutions contained in 96-well plates (using SoftMax Pro software (version 6.2.2)).
Synthesis
3-(4-methylcyclohexa-1,4-dien-1-yl)propanoic acid, 5 PTA (1,3,5-triaza-7-phosphaadamantane) 6 and silver oxalate 7 were synthesized according to literature procedures.
Compound 1: RuCl 3 •xH 2 O (2.82 g, 13.6 mmol, anhydrous basis) was dissolved in MeOH (10 ml) and the deep red solution allowed to boil dry. This process was repeated then the dark solid was dried under reduced pressure to remove residual traces of MeOH. To the solid was added 3-(4-methylcyclohexa-1,4-dien-1-yl)propanoic acid (5.08 g, 30.6 mmol), followed by the addition of acetone:H 2 O (60 ml, 5:1). The resulting dark solution was heated at reflux for 5 h, concentrated to 50 ml under reduced pressure then allowed to cool and stand at room temperature for 18 h. The resulting precipitate was isolated by filtration, washed with diethyl ether (10 ml) then dried under reduced pressure to yield the chlorido-bridged half-sandwich precursor to 1 as a dark red powder (3.65 g, 5.4 mmol, 79%). The product was used in the next step of the reaction without further purification.
The dark red powder was added to a suspension of silver oxalate (4.12 g, 13.6 mmol) in H 2 O (300 ml) and the mixture was stirred for 3 h. The resulting suspension was filtered through celite and the yellow filtrate dried under reduced pressure. The residue was then suspended in MeOH (200 ml) followed by the addition of PTA (2.13 g, 13.6 mmol). The yellow suspension was briefly sonicated then stirred at room temperature for 12 h. The yellow solid was then isolated by filtration, washed with cold MeOH (0°C, 50 ml), acetone (20 ml) and ether (20 ml) then dried under reduced pressure to afford 1 as a yellow powder (4.0 g, 7.8 mmol, 72% Compound 4a: 1 (100 mg, 0.196 mmol) and TBTU (63 mg, 0.196 mmol) were suspended in DMF (20 ml) and DIPEA (68 µl, 0.390 mmol) was added. The yellow suspension was stirred for 5 min and meso-1,2-diphenylethylenediamine (21 mg, 0.099 mmol) was added. The reaction mixture was stirred for a further 3 h under an atmosphere of N 2 then filtered to isolate a yellow solid, which was washed with DMF (5 ml) then acetone (10 ml), and then dried under high vacuum. The solid was suspended in boiling MeOH (50 ml) then filtered. The yellow solution was diluted by the addition of diethyl ether (20 ml) then allowed to stand at 4°C for 12 h. The resulting semi-crystalline material was collected by filtration then dried under reduced pressure to yield 4a as a yellow powder (35 mg, 0.029 mmol, 29%). For X-ray diffraction studies a quantity of the product was recrystallized by vapour diffusion of acetone into a H 2 O/acetone solution of 4a to yield yellow crystals. Compound 4b: Acetyl chloride (1 ml, 14.06 mmol) was added to anhydrous MeOH (15 ml) at 0°C under an atmosphere of N 2 . 4a (70 mg, 0.058 mmol) was then added as a solution in MeOH (10 ml) and DCM (10 ml), the solution rapidly turned red followed by the slow precipitation of a red solid. The mixture was stirred for 18 h then the solid collected by centrifugation and washed with MeOH (10 ml) to yield the hydrochloride salt of 4b as a red powder (60 mg, 0.046 mmol, 79% Compound 5a: 1 (200 mg, 0.392 mmol) and TBTU (126 mg, 0.392 mmol) were suspended in DMF (1 ml) and DIPEA (68 µl, 0.390 mmol) was added. The yellow suspension was stirred for 5 min followed by the addition of (1S,2S)-(-)-1,2-diphenylethylenediamine (37 mg, 0.174 mmol). The reaction mixture was stirred for a further 1.5 h under an atmosphere of N 2 , filtered to remove unreacted 1, then washed with cold DMF (2 ml). Acetone (20 ml) was added to the combined filtrates to yield a precipitate which was diluted by the addition of MeCN (5 ml), heated to 70°C then filtered to isolate a yellow solid which was washed with acetone (5 ml) then dried under high vacuum. The yellow solid was dissolved in boiling MeOH (100 ml), filtered and then concentrated to a volume of 5 ml, followed by the addition of acetone until precipitation began (approx. 0.5 ml). The suspension was left to stand at 4°C to produce a semi-crystalline precipitate which was isolated by decanting the solvent then washed with acetone (3 ml) and dried under reduced pressure to yield 5a as a yelloworange powder (40 mg, 0.033 mmol, 19%). For X-ray diffraction studies a quantity of the product was recrystallized by vapour diffusion of acetone into a H 2 O/acetone solution of 5a to yield yellow crystals. Compound 5b: Acetyl chloride (478 µl, 6.72 mmol) was added to anhydrous MeOH (5 ml) at 0°C under an atmosphere of N 2 . 5a (85 mg, 0.084 mmol) was then added as a solution in MeOH:DCM (3:2, 5 ml), the resultant yellow solution rapidly turned a red colour with the formation of a precipitate. The suspension was stirred for 12 h then the precipitate collected by filtration, washed with further MeOH (20 ml), then dried under reduced pressure to yield the hydrochloride salt of 5b as a red powder (50 mg, 0.038 mmol, 42% Compound 6a: 1 (209 mg, 0.409 mmol) and TBTU (126 mg, 0.392 mmol) were suspended in DMF (1 ml) and DIPEA (137 µl, 0.787 mmol) was added. The yellow suspension was stirred for 5 min, followed by the addition of (1R,2R)-(+)-1,2-diphenylethylenediamine (42 mg, 0.198 mmol). The reaction mixture was stirred for a further 2 h under an atmosphere of N 2 , filtered to remove unreacted 1, then washed with cold DMF (2 ml). Acetone (20 ml) was added to the combined filtrates to yield a precipitate which was collected by centrifugation then resuspended in MeCN (15 ml) and sonicated for 5 min. 
HPLC analysis of 5a and 6a
A suspension of complex 5a or 6a (3 mg) in DMF (50 µl) was heated at 50°C for 72 h resulting in a black suspension. The suspension was diluted with the addition of H 2 O (100 µl), extracted with DCM (2 x 100 µl) then the organic phase was dried under reduced pressure. The product was redissolved in MeOH (500 µl) and filtered through a disposable syringe filter (CHROMAFIL® Xtra H-PTFE-20/25) then dried under reduced pressure to yield the cleaved arene ligand, 5a-ligand or 6a-ligand (below). Figure S20: Electrospray-ionization mass spectra of 4b (top), 5b (middle) and 6b (bottom) after incubation with H-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-OH. Incubation conditions: 4b/5b/6b (0.6 mM), peptide (1 eq.) in H 2 O (72 h) at 310 K. Peak assignments are given using X = 4b/5b/6b.
H N (S) (S)
[X + 2OH + 2H 2 Cells were cultured in RPMI-1640 with GlutaMAX (A2780, A2780cisR) or DMEM high glucose with GlutaMAX (HEK 293) medium containing 10% fetal bovine serum (FBS) and penicillin at 37ºC and 5% CO 2 . A2780cisR cells were cultured in media containing cisplatin (2 µM) every second passage.
Cytotoxicity was determined using the MTT assay. 8 Cells were seeded in flat-bottomed 96-well plates by the addition of cells as a suspension in their respective media containing 10% FBS (100 μl per well, approximately 4300 cells) and pre-incubated for 24 h. Compound stock solutions were prepared in H 2 O immediately prior to use then diluted by the addition to the culture medium. These stock solutions were then sequentially diluted to yield compound solutions of the required concentrations. Aliquots (100 µl) of these stock solutions were added to plate wells to yield final compound concentrations in the range 0 µM to 300 µM/400 µM. For each cell line the cisplatin control was run at 0 µM to 75 µM. The 96-well plates were then incubated for a further 72 h followed by the addition of MTT (3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide) solution (20 μl, 5 mg/mL in H 2 O) to each well and the plates incubated for a further 2 h. The culture medium was then aspirated and the formazan precipitate produced by mitochondrial dehydrogenases of living cells was dissolved by the addition of DMSO (100 μl) to each well. The absorbance of the resultant solutions at 590 nm, which is directly proportional to the number of surviving cells, was recorded using a microplate reader. The percentage of surviving cells was determined by measurement of the absorbance of wells corresponding to untreated control cells. The reported IC 50 values are based on the mean values from two independent experiments; each concentration level per experiment was evaluated in triplicate, and those values are reported in Table 2 .
Cellular uptake studies
A2780 cells were seeded in 6 well plates in RPMI media (3 ml per well, approximately 240000 cells) and pre-incubated for 24 h. Media was then removed and replaced with fresh media containing either 2a, 3a, 4a, 5a or 6a (1 ml, 300 µM). The plates were incubated for 5 h followed by removal of media and the cells were washed with phosphate buffered saline (2 x 1 ml). Cells were then detached by the addition of enzyme-free cell dissociation solution (1 ml) then incubation at 37°C for 5 mins. An aliquot (800 µl) of the resulting cell suspension was then taken and the number of cells estimated using a hemocytometer. The cell suspension was dried under reduced pressure followed by the addition of HNO 3 (70%, 0.5 ml), briefly sonicated then allowed to stand for 18 h followed by the addition of H 2 O (4.5 ml). The solutions were filtered through syringe filters (0.20 µm) then kept frozen until analysis. The concentration of Ru (and therefore complex concentration per 10 6 cells) in each solution was determined by ICP-MS analysis, each reported value is the mean of three independent measurements less the background concentration of Ru found in untreated cells.
Measurement of complex lipophilicity
The lipophilicity of 2a-6a was compared by determining log P values using the shake-flask method as described in a literature procedure. 
